Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 15.73 is 85% above its 5-year average of 8.50, around the middle of its 5-year range (3.16–22.08).
As of the fiscal period ended Tuesday, June 30, 2026. 47.55% above its 12-month average of 10.66.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 15.73.
CURRENT RATIO
15.73
CURRENT RATIO AVG TTM
10.66
CURRENT RATIO AVG 3Y
9.92
CURRENT RATIO AVG 5Y
8.50
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+47.55%
CURRENT VS 3Y AVG
+58.67%
CURRENT VS 5Y AVG
+85.13%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.67
median of 822 covered companies
CURRENT VS SECTOR MEDIAN
+328.15%
vs the sector median at left
Praxis Precision Medicines, Inc.
Market Cap
$7.63B
Current Ratio
15.73
TTM Avg
10.66
3Y Avg
9.92
5Y Avg
8.50
Market Cap
$7.58B
Current Ratio
6.66
TTM Avg
5.35
3Y Avg
6.55
5Y Avg
8.14
Market Cap
$7.29B
Current Ratio
7.88
TTM Avg
6.15
3Y Avg
6.32
5Y Avg
6.43
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Praxis Precision Medicines, Inc. (PRAX) | $7.63B | 15.73 | 10.66 | 9.92 | 8.50 |
| HealthEquity, Inc. (HQY)vs › | $7.61B | 2.99 | 3.17 | 3.50 | 3.09 |
| Hinge Health, Inc. (HNGE)vs › | $7.61B | 1.34 | 1.90 | 2.23 | 2.23 |
| Cytokinetics, Incorporated (CYTK)vs › | $7.58B | 6.66 | 5.35 | 6.55 | 8.14 |
| TG Therapeutics, Inc. (TGTX)vs › | $7.92B | 4.27 | 5.17 | 4.86 | 5.25 |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.29B | 7.88 | 6.15 | 6.32 | 6.43 |
| Caris Life Sciences, Inc. (CAI)vs › | $8.01B | 5.53 | 4.58 | 3.87 | 3.23 |
| Alkermes plc (ALKS)vs › | $6.95B | 2.30 | 3.29 | 2.93 | 2.75 |
| Oscar Health, Inc. (OSCR)vs › | $8.40B | 1.08 | 0.93 | 1.08 | 1.24 |
| Kymera Therapeutics, Inc. (KYMR)vs › | $8.57B | 9.83 | 9.00 | 7.15 | 6.04 |
Current Ratio
15.73
Quick Ratio
15.73
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 15.73 |
| 2026-03-31 | 15.88 |
| 2025-12-31 | 10.22 |
| 2025-09-30 | 5.18 |
| 2025-06-30 | 6.31 |
| 2025-03-31 | 8.44 |
| 2024-12-31 | 10.77 |
| 2024-09-30 | 10.96 |
| 2024-06-30 | 17.30 |
| 2024-03-31 | 11.27 |
| 2023-12-31 | 5.39 |
| 2023-09-30 | 6.15 |
| 2023-06-30 | 5.31 |
| 2023-03-31 | 3.16 |
| 2022-12-31 | 3.23 |
| 2022-09-30 | 4.57 |
| 2022-06-30 | 4.56 |
| 2022-03-31 | 5.18 |
| 2021-12-31 | 7.48 |
| 2021-09-30 | 12.90 |
| 2021-06-30 | 22.08 |
| 2021-03-31 | 20.28 |
| 2020-12-31 | 19.23 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 6.67 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
